No profile data available.
Azenta, Inc. (AZTA) is a healthcare company in the laboratory analysis services industry, based in Burlington, United States, with about 2,900 full-time employees.
It reported revenue of $593.82 million for fiscal year 2025, down 9.5% from fiscal year 2024, and net income of -$55.76 million. Its largest business segment, Sample Management Solutions, brought in 55% of segment revenue in fiscal year 2025; United States was the largest region with 61%. Its market capitalization was $1.65 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of October 9, 2026.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments.
Azenta reported $593.82 million in revenue for fiscal year 2025, down 9.5% from $656.32 million in fiscal year 2024.
Sample Management Solutions, with $324.59 million or 55% of segment revenue in fiscal year 2025. Next: Multiomics (45%).
United States: 61% of revenue by region in fiscal year 2025, followed by Rest of Europe (18%).
$1.65 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (laboratory analysis services) include Personalis, Inc. (PSNL), Ginkgo Bioworks Holdings, Inc. (DNA), Dyadic International, Inc. (DYAI).